Recurrent Community-acquired Pneumonia in Patients Starting Acid-suppressing Drugs Dean T. Eurich, PhD, Cheryl A. Sadowski, PharmD, Scot H. Simpson, PharmD, Thomas J. Marrie, MD, Sumit R. Majumdar, MD, MPH The American Journal of Medicine Volume 123, Issue 1, Pages 47-53 (January 2010) DOI: 10.1016/j.amjmed.2009.05.032 Copyright © 2010 Elsevier Inc. Terms and Conditions
Figure 1 Cumulative incidence for community-acquired pneumonia readmission according to acid-suppressing drug use. The American Journal of Medicine 2010 123, 47-53DOI: (10.1016/j.amjmed.2009.05.032) Copyright © 2010 Elsevier Inc. Terms and Conditions
Figure 2 Risk of recurrent community-acquired pneumonia associated with exposure to acid-suppressing drug use. Conditional logistic regression analyses. Note nonusers of proton pump inhibitors/H2-receptor antagonists (PPI/H2s) reference category for all comparisons. The American Journal of Medicine 2010 123, 47-53DOI: (10.1016/j.amjmed.2009.05.032) Copyright © 2010 Elsevier Inc. Terms and Conditions